Organovo Holdings:Study Showed Statistically Significant Reduction in Liver Fat Content From Baseline in Patients Receiving Fxr314 Compared to Placebo
Organovo Holdings: 研究顯示,與安慰劑相比,接受Fxr314治療的患者的肝脂含量比基線顯著降低
Organovo Holdings:Study Showed Statistically Significant Reduction in Liver Fat Content From Baseline in Patients Receiving Fxr314 Compared to Placebo
Organovo Holdings: 研究顯示,與安慰劑相比,接受Fxr314治療的患者的肝脂含量比基線顯著降低
使用瀏覽器的分享功能,分享給你的好友吧